WHO prequalifies first typhoid conjugate vaccine for young children

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • WHO announced it has prequalified the Typhoid Vi Capsular Polysaccharide Tetanus Toxoid Conjugate (Typbar TCV, Bharat Biotech;TCV) for routine use in children aged 6 months in typhoid-endemic countries.
  • Prequalification indicates it has met WHO standards for quality, safety, an...